Afolabi, D; Albor, C; Zalewski, L; Altmann, DR; Baker, D; Schmierer, K; (2017) Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). p. 1352458517726380. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458517726380

Brownlee, WJ; Altmann, DR; Alves Da Mota, P; Swanton, JK; Miszkiel, KA; Wheeler-Kingshott, CG; Ciccarelli, O; Miller, DH; (2016) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458516663034

Brownlee, WJ; Miszkiel, KA; Altmann, DR; Ciccarelli, O; Miller, DH; (2016) Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458516667565

Kearney, H; Miszkiel, KA; Yiannakas, MC; Altmann, DR; Ciccarelli, O; Miller, DH; (2015) Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458515604905

Yiannakas, MC; Tozer, DJ; Schmierer, K; Chard, DT; Anderson, VM; Altmann, DR; Miller, DH; Wheeler-Kingshott, CAM; (2013) ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI. Multiple sclerosis (Houndmills, Basingstoke, England), 19 (6). pp. 732-741. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458512462074

Button, T; Altmann, D; Tozer, D; Dalton, C; Hunter, K; Compston, A; Coles, A; Miller, D; (2012) Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458512444915 Full text not available from this repository.

Tur, C; Penny, S; Khaleeli, Z; Altmann, D; Cipolotti, L; Ron, M; Thompson, A; Ciccarelli, O; (2011) Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458511410341 Full text not available from this repository.

Anderson, VM; Fisniku, LK; Khaleeli, Z; Summers, MM; Penny, SA; Altmann, DR; Thompson, AJ; Ron, MA; Miller, DH; (2010) Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Multiple sclerosis (Houndmills, Basingstoke, England), 16 (9). pp. 1083-1090. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458510374893 Full text not available from this repository.

Gorgoraptis, N; Wheeler-Kingshott, CA; Jenkins, TM; Altmann, DR; Miller, DH; Thompson, A; Ciccarelli, O; (2010) Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458510362440

Papadopoulos, K; Tozer, DJ; Fisniku, L; Altmann, DR; Davies, G; Rashid, W; Thompson, AJ; Miller, DH; Chard, DT; (2010) T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458509359924 Full text not available from this repository.

Swanton, J; Fernando, K; Dalton, C; Miszkiel, K; Altmann, D; Plant, G; Thompson, A; Miller, D; (2010) Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458509353650 Full text not available from this repository.

Anderson, V; Fisniku, L; Altmann, D; Thompson, A; Miller, D; (2009) MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. Multiple sclerosis (Houndmills, Basingstoke, England), 15 (7). pp. 811-7. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458508101934 Full text not available from this repository.

Fisniku, L; Altmann, D; Cercignani, M; Tozer, D; Chard, D; Jackson, J; Miszkiel, K; Schmierer, K; Thompson, A; Miller, D; (2009) Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 15 (6). pp. 668-77. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458509103715 Full text not available from this repository.

Furby, J; Hayton, T; Altmann, D; Brenner, R; Chataway, J; Smith, K; Miller, D; Kapoor, R; (2009) Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 15 (6). pp. 687-94. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458509103176 Full text not available from this repository.

Anderson, VM; Fisniku, LK; Altmann, D; Chard, DT; Thompson, AJ; Miller, DH; (2008) Reduced cerebellar grey matter volume is associated with cerebellar dysfunction in multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5862 Full text not available from this repository.

Chataway, J; Chan, D; Anderson, V; Polito, B; Kallis, C; Frost, C; Calder, V; Greenwood, J; Nicholas, R; , Mstc; (2008) The MS-STAT trial: a Phase II trial of high dose simvastatin in secondary progressive multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5823 Full text not available from this repository.

Fisniku, LK; Brex, PA; Chard, DT; Jackson, J; Altmann, D; Miszkiel, KA; Thompson, AJ; Miller, D; (2008) Changes in brain lesion load over 20 years and subsequent brain atrophy in clinically isolated syndrome patients. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5864 Full text not available from this repository.

Furby, J; Hayton, T; Anderson, V; Altmann, D; Brenner, R; Chataway, J; Hughes, RA; Smith, KJ; Miller, DH; Kapoor, R; (2008) Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 14 (8). pp. 1068-75. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458508093617 Full text not available from this repository.

Furby, J; Hayton, T; Smith, KJ; Altmann, D; Brenner, R; Chataway, J; Hughes, RA; Miller, D; Kapoor, R; (2008) White matter lesion characteristics predict types of gray matter abnormality on magnetic resonance imaging in secondary progressive multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5865 Full text not available from this repository.

Jenkins, T; Mancini, L; Ciccarelli, O; Toosy, A; Altmann, D; Chappell, K; Plant, G; Miller, D; Thompson, AJ; (2008) Using structural and functional magnetic resonance imaging to explain visual loss at the onset of acute optic neuritis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5866 Full text not available from this repository.

Swanton, JK; Kryshani, FT; Dalton, C; Miszkiel, KA; Altmann, DR; Plant, G; Chard, DT; Thompson, AJ; Miller, DH; (2008) Predicting disability in patients presenting with optic neuritis: the role of early magnetic resonance imaging parameters. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5867 Full text not available from this repository.

di Filippo, M; Anderson, VM; Altmann, D; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH; (2008) Early brain atrophy and lesion load measures relate to clinical status after six years in patients with clinically isolated syndromes. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5863 Full text not available from this repository.

Anderson, VM; Altmann, DR; Fisniku, L; Fox, NC; Miller, DH; (2007) Effects of an MRI scanner upgrade on longitudinal measures of brain atrophy and application of a statistical correction method. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/7964 Full text not available from this repository.

Davies, GR; Hadjiprocopis, A; Altmann, DR; Chard, DT; Griffin, CM; Rashid, W; Parker, GJ; Tofts, PS; Kapoor, R; Thompson, AJ; +1 more... Miller, DH; (2007) Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. Multiple sclerosis (Houndmills, Basingstoke, England), 13 (2). pp. 169-77. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458506070726 Full text not available from this repository.

Hayton, T; Furby, J; Smith, K; Altmann, D; Brenner, R; Chataway, J; Fox, NC; Hughes, RAC; Miller, DH; Kapoor, R; (2007) Correlation between brain magnetisation transfer ratio and clinical disability measures in secondary progressive multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/7966 Full text not available from this repository.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. Multiple sclerosis (Houndmills, Basingstoke, England), 13 (2). pp. 178-85. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458506070758 Full text not available from this repository.

Sastre-Garriga, J; Altmann, DR; Ingle, G; Ramio-Torrenta, L; Khadeeli, Z; McLean, MA; Miller, DH; Thompson, AJ; (2007) Disability prediction in early PPMS using a magnetic resonance multiparameter approach. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/7965 Full text not available from this repository.

Soon, D; Tozer, Dj; Altmann, D; Tofts, P; Miller, D; (2007) Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Multiple sclerosis (Houndmills, Basingstoke, England), 13 (7). pp. 884-94. ISSN 1352-4585 DOI: https://doi.org/10.1177/1352458507076970 Full text not available from this repository.

Anderson, VM; Bartlett, JW; Fisniku, L; Davies, GR; Rashid, W; Fox, NC; Miller, DH; (2006) Sample size estimates based on hierarchical regression models of atrophy rates in relapsing-remitting multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/9699 Full text not available from this repository.

Chong, MS; Wolff, K; Wise, K; Tanton, C; Winstock, A; Silber, E; (2006) Cannabis use in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 12 (5). pp. 646-651. ISSN 1352-4585 DOI: https://doi.org/10.1177/135248506070947 Full text not available from this repository.

Drapier, S; Swanton, J; Altmann, D; Fernando, KTM; Dalton, C; Thompson, AJ; Plant, G; Miller, DH; (2006) Increasing cord atrophy in clinical isolated syndrome group: a 5-year study. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/9616 Full text not available from this repository.

Furby, J; Hayton, T; Smith, KJ; Altmann, D; Brenner, R; Chataway, J; Fox, NC; Hughes, RAC; Miller, DH; Kapoor, R; (2006) A randomised controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/9617 Full text not available from this repository.

Davies, GR; Altmann, DR; Rashid, W; Chard, DT; Griffin, CM; Barker, GJ; Kapoor, R; Thompson, AJ; Miller, DH; (2005) Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 11 (3). pp. 276-81. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458505ms1166oa Full text not available from this repository.

Lim, ET; Sellebjerg, F; Jensen, CV; Altmann, DR; Grant, D; Keir, G; Thompson, EJ; Giovannoni, G; (2005) Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 11 (5). pp. 532-6. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458505ms1218oa Full text not available from this repository.

Soon, D; Altmann, DR; Barkhof, F; Fernando, KTM; Giovannoni, G; Gray, B; O'Connor, PW; Panzara, MA; Polman, C; Miller, DH; (2005) Subtle blood brain barrier leakage in non-enhancing lesions in relapsing multiple sclerosis: multi-centre study of patients in a therapeutic trial. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/12440 Full text not available from this repository.

Chard, DT; Griffin, CM; Rashid, W; Davies, GR; Altmann, DR; Kapoor, R; Barker, GJ; Thompson, AJ; Miller, DH; (2004) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 10 (4). pp. 387-91. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458504ms1050oa Full text not available from this repository.

Schmierer, K; Altmann, DR; Kassim, N; Kitzler, H; Kerskens, CM; Doege, CA; Aktas, O; Lunemann, JD; Miller, DH; Zipp, F; +1 more... Villringer, A; (2004) Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Multiple sclerosis (Houndmills, Basingstoke, England), 10 (2). pp. 182-7. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458504ms996oa Full text not available from this repository.

Wade, DT; Makela, P; Robson, P; House, H; Bateman, C; (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Multiple sclerosis (Houndmills, Basingstoke, England), 10 (4). pp. 434-41. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458504ms1082oa Full text not available from this repository.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Multiple sclerosis (Houndmills, Basingstoke, England), 9 (4). pp. 411-419. ISSN 1352-4585 DOI: https://doi.org/10.1191/1352458503ms929oa Full text not available from this repository.

Hobart, J; Riazi, A; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) Choosing quality of life measures for clinical trials of multiple sclerosis (MS): Evidence-based measurement. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/11040 Full text not available from this repository.

Hobart, J; Riazi, A; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29): Reliability and validity in hospital-based samples. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/11039 Full text not available from this repository.

Hobart, J; Wright, B; Fitzpatrick, R; Lamping, D; Riazi, A; Thompson, A; (2001) Quality of life measurement: Is Rasch item analysis too good to be true? [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/11038 Full text not available from this repository.

Riazi, A; Hobart, J; Lamping, D; Fitzpatrick, R; Freeman, J; Thompson, A; (2001) Socio-demographic predictors of health-related quality of life in multiple sclerosis and comparisons with other populations. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/11041 Full text not available from this repository.